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Summary
Purpose of review—The assumption that fructose may be “toxic” and involved in the
pathogenesis of non communicable diseases such as obesity, diabetes mellitus, dyslipidemia, and
even cancer has resulted in the call for public health action, such as introducing taxes on
sweetened beverages. This review evaluates the scientific basis for such action.
Recent findings—Although some studies hint towards some potential adverse effects of
excessive fructose consumption especially when combined with excess energy intake, the results
from clinical trials do not support a significant detrimental effect of fructose on metabolic health
when consumed as part of a weight maintaining diet in amounts consistent with the average
estimated fructose consumption in Western countries. However, definitive studies are missing.
Summary and conclusion—Public health policies to eliminate or limit fructose in the diet
should be considered premature. Instead, efforts should be made to promote a healthy life style
that includes physical activity and nutritious foods while avoiding intake of excess calories until
solid evidence to support action against fructose is available. Public health is almost certainly to
benefit more from policies that are aimed at promoting what is known to be good than from
policies that are prohibiting what is not (yet) known to be bad.
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Introduction
Recently, the potential adverse metabolic effects of sugars, in particular fructose have been
the focus of attention. The assumption that fructose, especially when consumed with
sweetened beverages, may be “toxic” and involved in the pathogenesis of non
communicable diseases such as obesity, diabetes mellitus, dyslipidemia, and even cancer has
been spurred by the introduction of high fructose corn syrup (HFCS) and the concomitant
increase in obesity (1). This concept has been of major interest to journalistic inquisitiveness
and has been promoted in the lay press (2), as well as in articles published in high impact
peer-reviewed journals (3). The suspicion about specifically deleterious effects of fructose
has resulted in the call for public health action, such as introducing taxes on sweetened
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beverages (4). These statements have had a wide echo and may be influential in devising
public health actions in the fight against obesity and related diseases. Indeed, taxes on
sweetened (with sugar or HFCS) beverages have been introduced in France at the beginning
of this year, and are presently being considered in several other countries around the world.
One may however question whether such action would rest on solid scientific and clinical
evidence.
Sources of fructose in our diet
An immediate difficulty one encounters when trying to evaluate the scientific literature is to
identify what is the potential deleterious factor we are talking about. Based on biochemical
considerations and some experimental evidence, fructose may indeed be the main target, due
to the fact that it is essentially metabolized in splanchnic tissues, and that its metabolism and
conversion into other intermediary substrates is not regulated by insulin or the energy status
of the liver (5). However, there is no food containing pure fructose only, and fructose and
glucose are always co-ingested, either as free hexoses in fruits and honey, or as free glucose-
fructose mixtures in HFCS, or bound together as sucrose. In HFCS, which is produced by
processing corn starch to yield glucose, and then processing the glucose to produce a syrup
that contains various amounts of fructose, the most commonly used grade (and that found in
soft drinks) is HFCS 55 which contains 55% fructose and 45% glucose; roughly the same as
the fructose to glucose ratio in sucrose (6). Thus, fructose intake is essentially proportional
to caloric sweetener intake regardless of whether the sweetener is sucrose (sugar) or HFCS.
In the USA and in Europe, half of the added sugar intake results from consumption of
sweetened solid food items (yogurt, cereal bars, chocolate bars, ice-creams, etc.) and half
from consumption of sweetened beverages (regular sodas, fruit juices, energy drinks, sport
drinks, and sweetened milk products) (7). Approximately 50% of the added sugar intake
comes from sucrose and 50% from HFCS, with fructose accounting for ∼ 10% of total
calorie intake (7, 8). Therefore, it is difficult to dissect the effect of fructose per se from the
effect of added sugar intake (regardless of whether it comes from beverages or other food
items) in any practically meaningful way. Along the same lines, evaluating the effect of
added sugar intake carries the question of whether or not to account for the extra calories or
not and what calories to use as a replacement (i.e., coke vs. water, coke vs. milk, coke vs.
diet coke, sugar vs. glucose? etc). Now, what have we learned so far and where does the fear
of fructose coming from? Is it legitimate?
Observations collected from epidemiological studies
Due to the fact that most nutritional tables used for epidemiological studies did not
specifically include fructose data, the bulk of epidemiological studies have assessed the
relationship between metabolic diseases on one hand, and either sugar intake or sweetened
beverage intake on the other hand. A comprehensive review of these studies is beyond the
scope of this editorial but most report that sugar/calorically sweetened beverage intake is
associated with increased body weight and obesity (9). Interpretation of these results
however is complicated because sweetened beverage intake is also associated with increased
total energy intake and increased consumption of processed and high-fat foods (such as fried
potato products and processed meats) as well as reduced consumption of fruits and
vegetables and reduced physical activity (10). In fact, several studies that adjusted for total
energy intake in their analysis failed to observe a direct positive relationship between sugar
intake and obesity (11-13). Not surprisingly, a recent meta-analysis including 41 short-term
intervention trials concluded that fructose increased body weight when included in a
hypercaloric, but not when included in an energy balanced, isocaloric diet (14). In addition,
although, it has been proposed that fructose may be less satiating than other carbohydrates
(15), and that consumption of sugar with sweetened beverages is incompletely compensated
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by a reduction of solid food intake (16), a recent systematic review of the literature on this
topic concluded that there is no consistent evidence that fructose effects body weight when
consumed at levels corresponding to usual, western intake (17). Associations between sugar
and/or sweetened beverage intake and diabetes, dyslipidemia, non-alcoholic fatty liver
disease, and markers of cardiovascular diseases have also been reported (18-20). However,
these associations were not independent of body weight. The data collected from
epidemiological studies therefore support the idea that sugar and sweetened beverage
consumption most likely contribute quite significantly to excess energy intake and obesity,
but do not demonstrate that fructose per se or even just sugar are responsible for increased
energy intake or metabolic diseases.
Observations collected from clinical trials
In general, the results from clinical trials do not support a significant detrimental effect of
fructose on metabolic health and although some studies hint towards some potential adverse
effects, the clinical relevance of these findings is unclear. Many short term studies,
performed in the 1980's showed that fructose substituted for starch or sucrose, increased
fasting and postprandial triglyceride concentrations in healthy subjects and in type 2
diabetes patients (21). Since then, several overfeeding studies in non-obese and overweight
subjects have confirmed the hypertriglyceridemic effect of fructose (22-24). When
consumed in amounts consistent with the average estimated fructose consumption by
Americans and other people from Western societies, fructose did not affect plasma lipid
concentrations (25, 26) but it increased the number of small dense LDL particles, which may
be associated with an increased cardiovascular risk (27). Twenty four hour glucose and
insulin concentrations are also not adversely affected by a diet providing as much as 25% of
energy as fructose (equivalent to ∼50% of dietary caloric intake as sugar or HFCS) for 10
weeks; in fact fructose lowered plasma glucose and insulin concentrations (28, 29). Even in
the context of fructose overfeeding, providing about 30% excess energy via fructose, whole-
body insulin-mediated glucose disposal, assessed by using the gold-standard
hyperinsulinemic-euglycemic clamp technique, was unchanged (22, 23, 30) and fasting
hepatic glucose production was only marginally increased by about 14% (30). Furthermore,
as far as we can tell, only one study has found that consumption of 200 g of fructose per day
during 2 weeks increased blood pressure (31) whereas others report no effect (22, 24) and a
recent meta-analysis including 13 isocaloric and 2 hypercaloric fructose feeding intervention
studies concluded that substitution of fructose for other carbohydrates did not adversely
affect blood pressure in human subjects (32).
Of significant concern could be the potential of fructose to preferentially increase visceral
fat deposition and stimulate ectopic fat accumulation, especially in the liver. However, so far
fructose-related increases in visceral and ectopic fat accumulation have only been observed
in subjects who consumed quite substantial amounts (about 150 g/d or more) of fructose for
1 week up to 6 months and either received a hypercaloric diet per design or gained
significant amounts of weight during the study (23, 24, 33) so it is unclear how much of the
increase in these fat depots is simply due to excess energy intake. The mechanisms
responsible for increased hepatic fat deposition during fructose overfeeding studies involve a
stimulation of hepatic de novo lipogenesis and an inhibition of adipose lipolysis and hepatic
lipid oxidation (23, 24, 30). Furthermore, there is concern that fructose may cause hepatic
inflammation and accelerate the progression of non-alcoholic fatty liver disease (NAFLD) to
non-alcoholic steatohepatitis (NASH). In rodent studies, fructose not only induces hepatic
steatosis but also enhances hepatic TNF-α and PAI-1 production (34, 35), two mediators
thought to be involved in liver inflammation, and stimulates the progression of NAFLD to
NASH in animals fed a high saturated fat diet (36). It also impairs liver regeneration after
partial hepatectomy (36). Thus , there is concern that fructose may exert a pro-inflammatory
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effect on liver cells, which, when combined with other risk factors, such as excess energy or
high fat intake or low physical activity, may trigger progression of NAFLD to NASH.
So, is there a need for public policy against fructose or rather a need for
more scientific inquiry?
There are indeed reasons to be concerned about an excessive intake of fructose and a call for
limiting its consumption is in place because excess energy intake in the form of fructose
(just like any other energy source) is associated with excess body weight and metabolic
alterations that often accompany obesity. However, there is clearly a need for more
clinically relevant research before taking drastic public health actions to specifically target
fructose-containing caloric sweeteners, which may divert authorities from other, possibly
more important public health actions, such as promoting an increase in physical activity, a
decrease in energy consumption in general and an increase in the consumption of fresh fruit
and vegetables because there is little evidence that fructose itself causes significant
metabolic alterations when consumed in amounts that are consistent with current dietary
habits. However, crucial studies that will provide definitive answers to the concerns of
fructose toxicity and others which should guide decisions of public policy makers are still
missing. What are they?
1. What are the metabolic effects of fructose when consumed in amounts consistent
with that consumed on average in the general population under conditions of
weight stability?
2. Are there beneficial effects to removing fructose, especially sugar/HFCS-
sweetened beverages, from the diet and will it decrease obesity in the population
(or simply shift the consumption of excess energy from beverages to other items)?
In this regard, there is an urgent need for intervention studies. Recently the
CHOICE study indicated that replacing sweetened beverages by non caloric
beverages in a group of overweight adults led to a 2 % weight loss after 6 months
(37). However, avoiding these beverages was a choice made with the intent to lose
weight and equal amounts of weight were lost in the control subjects who reduced
calorie intake through cutting down on foods of their choice. Which leads to the
next question.
3. What are the consequences of “forcing” fructose, especially HFCS-sweetened
beverages from the market? Will this result in an increase in the use of sugar again
or an increase in artificial sweetener consumption and if so, is this safer? Or might
a ban of sweetened beverages simply shift the consumption of sugar/HFCS in
beverages to the consumption of sugar in other goods to satisfy ones sweet tooth?
4. Does dietary sugar/HFCS/fructose, especially when consumed in the form of
beverages, impair the control of food intake and induce excessive energy intake
(38)? So far, there is no compelling evidence for this, but studies have mostly been
limited to single meals (39-42).
5. What are the long term effects of heavy fructose consumption? So far most studies
have been limited to relative short-term interventions. However, given the fact that
marked alterations of molecular events can be observed over short periods and that
alterations of glucose homeostasis can be documented within a few days to weeks
in animal models (43), it appears unlikely that alterations of energy metabolism or
endocrine regulations independent of a body fat increase would take several years
in human subjects.
Tappy and Mittendorfer Page 4
Curr Opin Clin Nutr Metab Care. Author manuscript; available in PMC 2013 July 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
6. Are there particularly susceptible populations and what are the reasons for their
increased susceptibility? In rats, fructose causes adverse metabolic effects in males
and in oophorectomized females, but not in non-oophorectomized females (44). In
humans, short term fructose overfeeding also produced much blunted metabolic
effects in pre-menopausal females (45-47). It has also been suggested that fructose
causes more significant metabolic alterations in insulin resistant subjects (48).
Finally, it has been proposed that the consequences of sugar consumption on
hepatic fat may vary according to ethnic groups and genetic variations (49). The
concept that susceptibility to fructose may be different presently rests on a small
number of studies, and needs to be assessed more broadly in a public health
perspective.
Conclusion
Rather than damning fructose, efforts should be made to promote a healthy life style that
includes physical activity and fresh fruits and vegetables while avoiding intake of excess
calories until solid evidence to support action against fructose is available. Public health is
almost certainly to benefit more from policies that are aimed at promoting what is known to
be good than from policies that are prohibiting what is not (yet) known to be bad.
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Key bullet points
• There is some evidence that suggests excessive fructose consumption especially
when combined with excess energy intake may have adverse effects on
metabolic health.
• The results from clinical trials do not support a significant detrimental effect of
fructose on metabolic health when consumed as part of a weight maintaining
diet in amounts consistent with the average estimated fructose consumption in
Western countries.
• Public health policies to eliminate or limit fructose in the diet should be
considered premature.
• Crucial studies that will provide definitive answers to the concerns of fructose
toxicity and others which should guide decisions of public policy makers are
still missing.
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